Dr. Stewart Goldman, MD
Claim this profileLurie Children's Hospital-Chicago
Studies Brain Tumor
Studies Cerebral Gliomas
13 reported clinical trials
26 drugs studied
Area of expertise
1Brain Tumor
H3.3K27M positive
IDH positive
H3F3A
2Cerebral Gliomas
H3.3K27M positive
IDH positive
H3F3A
Affiliated Hospitals
Clinical Trials Stewart Goldman, MD is currently running
CX-4945
for Medulloblastoma
This trial tests an oral drug called CX-4945 for patients with a recurring type of brain tumor. The drug aims to block a protein that helps cancer cells grow. The study will determine the best dose and check for side effects. CX-4945 has shown promising results in other types of cancer and may be developed as a new therapy.
Recruiting1 award Phase 1 & 25 criteria
PARP Inhibitor + Temozolomide
for Brain Cancer
This trial studies the safety and best dose of BGB-290 and temozolomide in treating young people with a specific type of brain tumor. BGB-290 blocks enzymes needed for tumor growth, while temozolomide kills or stops cancer cells from growing. The goal is to find out if this combination works better for these patients.
Recruiting1 award Phase 1
More about Stewart Goldman, MD
Clinical Trial Related8 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Stewart Goldman, MD has experience with
- Optune System
- BGB-290
- Temozolomide
- Nivolumab
- K27M Peptide
- CX-4945
Breakdown of trials Stewart Goldman, MD has run
Brain Tumor
Cerebral Gliomas
Diffuse Intrinsic Pontine Glioma
Brain Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stewart Goldman, MD specialize in?
Stewart Goldman, MD focuses on Brain Tumor and Cerebral Gliomas. In particular, much of their work with Brain Tumor has involved H3.3K27M positive patients, or patients who are IDH positive.
Is Stewart Goldman, MD currently recruiting for clinical trials?
Yes, Stewart Goldman, MD is currently recruiting for 3 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Stewart Goldman, MD has studied deeply?
Yes, Stewart Goldman, MD has studied treatments such as Optune System, BGB-290, Temozolomide.
What is the best way to schedule an appointment with Stewart Goldman, MD?
Apply for one of the trials that Stewart Goldman, MD is conducting.
What is the office address of Stewart Goldman, MD?
The office of Stewart Goldman, MD is located at: Lurie Children's Hospital-Chicago, Chicago, Illinois 60611 United States. This is the address for their practice at the Lurie Children's Hospital-Chicago.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.